U.S. Funding of Wuhan Coronavirus Research: A Timeline of the Obama and Trump Years

Click to expand image

 

The question of whether U.S. taxpayer dollars funded coronavirus research at China's Wuhan Institute of Virology (WIV) has remained one of the most contentious issues to emerge from the COVID-19 pandemic. While the broad answer is yes, the details—and whether that research should be classified as "gain-of-function"—have been the subject of years of scientific, political, and regulatory debate.

Here's a chronological look at what happened.

2014: NIH Awards EcoHealth Alliance Grant

In 2014, during the Obama administration, the National Institutes of Health (NIH) awarded EcoHealth Alliance a grant titled "Understanding the Risk of Bat Coronavirus Emergence."

The grant totaled approximately $3.4–$3.7 million over several years.

EcoHealth Alliance, a New York-based nonprofit led by Peter Daszak, partnered with scientists at the Wuhan Institute of Virology. Approximately $600,000 of the grant was sent to WIV through a subaward to collect bat coronaviruses, analyze their genetics, and conduct laboratory experiments.

October 2014: Obama Administration Pauses Certain Gain-of-Function Research

Later that year, the Obama administration announced a federal pause on funding certain gain-of-function experiments involving influenza, SARS, and MERS viruses.

The pause applied to research that could reasonably be expected to increase a virus's transmissibility or pathogenicity.

However, the EcoHealth grant continued after NIH determined it did not fall under the specific criteria requiring suspension. This decision would later become one of the central points of controversy.

2014–2019: Coronavirus Research Continues

Over the next several years, EcoHealth Alliance and researchers at Wuhan collected thousands of bat virus samples throughout China.

Some experiments involved creating chimeric coronaviruses by combining spike proteins from naturally occurring bat viruses with established SARS-related viral backbones. Researchers then tested whether these engineered viruses could infect human cells or humanized laboratory mice.

Supporters argued this work helped scientists understand which viruses posed the greatest pandemic threat.

Critics argued these experiments amounted to gain-of-function research because they intentionally altered viruses to study increased infectivity.

2017: Trump Administration Ends Federal Gain-of-Function Pause

In December 2017, the Trump administration officially lifted the Obama-era funding pause.

The Department of Health and Human Services replaced it with the Potential Pandemic Pathogen Care and Oversight (P3CO) Framework, creating a review process for research involving enhanced potential pandemic pathogens rather than imposing a blanket prohibition.

This policy change applied government-wide and was not directed specifically at Wuhan or EcoHealth Alliance.

2019: NIH Renews EcoHealth Grant

The NIH renewed the EcoHealth Alliance grant during the Trump administration.

Although much of the Wuhan funding had already been distributed during the Obama years, approximately $265,000 in additional subaward funding flowed to WIV during President Trump's first term under the renewed grant.

Early 2020: COVID-19 Sparks Global Scrutiny

After COVID-19 emerged in Wuhan, lawmakers and journalists began examining whether U.S. taxpayer dollars had supported research at the Wuhan Institute of Virology.

Attention quickly focused on EcoHealth Alliance and its NIH-funded collaboration with WIV.

April 17, 2020: President Trump Signals Funding Will End

During a White House briefing, President Donald Trump was asked about the NIH grant supporting Wuhan research.

Trump responded that his administration would end the funding and said the grant should have never been approved.

April 24, 2020: NIH Terminates the Grant

One week later, the NIH officially terminated EcoHealth Alliance's grant.

NIH informed EcoHealth that the project no longer aligned with agency priorities, effectively ending federal funding for the Wuhan collaboration.

Anthony Fauci later testified before Congress that the White House directed NIH to cancel the grant.

This marked the end of U.S. funding flowing to WIV through that particular NIH grant.

2021: NIH Acknowledges Reporting Failure

In October 2021, NIH Principal Deputy Director Lawrence Tabak informed Congress that EcoHealth Alliance had failed to promptly report an unexpected experimental result required under its grant conditions.

The experiment involved a laboratory-created coronavirus that produced significantly higher viral loads in humanized mice than expected.

NIH stated the reporting requirement had not been met, leading to renewed criticism of EcoHealth's oversight and compliance.

Was It Gain-of-Function Research?

The answer depends largely on which definition is being used.

NIH officials, including Anthony Fauci and Francis Collins, consistently maintained that the research did not meet the agency's formal definition of gain-of-function research requiring special oversight under federal policy. They argued the experiments were not expected to increase transmissibility or lethality in humans and therefore did not qualify under the applicable regulatory framework.

Many outside scientists disagreed. Researchers such as molecular biologist Richard Ebright argued that creating chimeric coronaviruses and testing whether they became more infectious or pathogenic fit the ordinary scientific understanding of gain-of-function research, regardless of how NIH classified it administratively.

The disagreement has centered less on what experiments were performed than on how federal policy defined gain-of-function at the time.

Bottom Line

There is broad agreement on several key facts:

• U.S. taxpayer funds supported coronavirus research at the Wuhan Institute of Virology through NIH grants awarded to EcoHealth Alliance.
• The funding began during the Obama administration in 2014 and continued into President Trump's first term after the grant was renewed.
• The Trump administration terminated the primary NIH grant on April 24, 2020, shortly after COVID-19 became a global pandemic and questions arose about the Wuhan laboratory.
• Whether the funded experiments should be labeled "gain-of-function" remains disputed. NIH has maintained they did not meet its regulatory definition, while many independent scientists contend the work fits the broader scientific meaning of the term.
• Subsequent investigations found that EcoHealth Alliance failed to promptly report certain experimental results required under the grant, leading to additional federal actions against the organization in later years.

The debate over the Wuhan research has therefore evolved beyond whether U.S. funding existed—which is well documented—to questions about oversight, transparency, regulatory definitions, and the level of risk associated with the experiments that federal dollars helped support.